1. Home
  2. CYTK vs RHI Comparison

CYTK vs RHI Comparison

Compare CYTK & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • RHI
  • Stock Information
  • Founded
  • CYTK 1997
  • RHI 1948
  • Country
  • CYTK United States
  • RHI United States
  • Employees
  • CYTK N/A
  • RHI N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • RHI Professional Services
  • Sector
  • CYTK Health Care
  • RHI Consumer Discretionary
  • Exchange
  • CYTK Nasdaq
  • RHI Nasdaq
  • Market Cap
  • CYTK 4.6B
  • RHI 3.7B
  • IPO Year
  • CYTK 2004
  • RHI N/A
  • Fundamental
  • Price
  • CYTK $53.01
  • RHI $37.05
  • Analyst Decision
  • CYTK Buy
  • RHI Hold
  • Analyst Count
  • CYTK 15
  • RHI 5
  • Target Price
  • CYTK $75.57
  • RHI $49.80
  • AVG Volume (30 Days)
  • CYTK 2.6M
  • RHI 1.7M
  • Earning Date
  • CYTK 11-05-2025
  • RHI 10-21-2025
  • Dividend Yield
  • CYTK N/A
  • RHI 6.35%
  • EPS Growth
  • CYTK N/A
  • RHI N/A
  • EPS
  • CYTK N/A
  • RHI 1.75
  • Revenue
  • CYTK $85,738,000.00
  • RHI $5,569,026,000.00
  • Revenue This Year
  • CYTK $330.96
  • RHI N/A
  • Revenue Next Year
  • CYTK $73.41
  • RHI $3.32
  • P/E Ratio
  • CYTK N/A
  • RHI $21.21
  • Revenue Growth
  • CYTK 2635.74
  • RHI N/A
  • 52 Week Low
  • CYTK $29.31
  • RHI $33.18
  • 52 Week High
  • CYTK $59.39
  • RHI $78.41
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 77.96
  • RHI 48.45
  • Support Level
  • CYTK $35.22
  • RHI $36.07
  • Resistance Level
  • CYTK $50.22
  • RHI $37.59
  • Average True Range (ATR)
  • CYTK 2.29
  • RHI 1.03
  • MACD
  • CYTK 1.64
  • RHI 0.27
  • Stochastic Oscillator
  • CYTK 94.73
  • RHI 51.95

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About RHI Robert Half Inc.

Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.

Share on Social Networks: